FR2716460B1 - Modèle animal de la maladie d'Alzheimer, préparation et utilisations. - Google Patents

Modèle animal de la maladie d'Alzheimer, préparation et utilisations.

Info

Publication number
FR2716460B1
FR2716460B1 FR9401922A FR9401922A FR2716460B1 FR 2716460 B1 FR2716460 B1 FR 2716460B1 FR 9401922 A FR9401922 A FR 9401922A FR 9401922 A FR9401922 A FR 9401922A FR 2716460 B1 FR2716460 B1 FR 2716460B1
Authority
FR
France
Prior art keywords
alzheimer
disease
preparation
animal model
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9401922A
Other languages
English (en)
Other versions
FR2716460A1 (fr
Inventor
Pascal Barneoud
Pia Delaere
Luc Mercken
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CT NAL RECH SCIENT
Institut Gustave Roussy (IGR)
Aventis Pharma SA
Original Assignee
CT NAL RECH SCIENT
Rhone Poulenc Rorer SA
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CT NAL RECH SCIENT, Rhone Poulenc Rorer SA, Institut Gustave Roussy (IGR) filed Critical CT NAL RECH SCIENT
Priority to FR9401922A priority Critical patent/FR2716460B1/fr
Priority to PCT/FR1995/000187 priority patent/WO1995022616A1/fr
Priority to EP95909839A priority patent/EP0734447A1/fr
Priority to JP7521633A priority patent/JPH09509059A/ja
Priority to AU18156/95A priority patent/AU1815695A/en
Priority to CA 2182724 priority patent/CA2182724A1/fr
Publication of FR2716460A1 publication Critical patent/FR2716460A1/fr
Application granted granted Critical
Publication of FR2716460B1 publication Critical patent/FR2716460B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
FR9401922A 1994-02-21 1994-02-21 Modèle animal de la maladie d'Alzheimer, préparation et utilisations. Expired - Fee Related FR2716460B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9401922A FR2716460B1 (fr) 1994-02-21 1994-02-21 Modèle animal de la maladie d'Alzheimer, préparation et utilisations.
PCT/FR1995/000187 WO1995022616A1 (fr) 1994-02-21 1995-02-17 Modele animal de la maladie d'alzheimer, preparation et utilisations
EP95909839A EP0734447A1 (fr) 1994-02-21 1995-02-17 Modele animal de la maladie d'alzheimer, preparation et utilisations
JP7521633A JPH09509059A (ja) 1994-02-21 1995-02-17 アルツハイマー病の動物モデル、調製方法および使用
AU18156/95A AU1815695A (en) 1994-02-21 1995-02-17 Animal model of the alzheimer disease, preparation and utilisations
CA 2182724 CA2182724A1 (fr) 1994-02-21 1995-02-17 Modele animal de la maladie d'alzheimer, preparation et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401922A FR2716460B1 (fr) 1994-02-21 1994-02-21 Modèle animal de la maladie d'Alzheimer, préparation et utilisations.

Publications (2)

Publication Number Publication Date
FR2716460A1 FR2716460A1 (fr) 1995-08-25
FR2716460B1 true FR2716460B1 (fr) 2002-08-09

Family

ID=9460258

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9401922A Expired - Fee Related FR2716460B1 (fr) 1994-02-21 1994-02-21 Modèle animal de la maladie d'Alzheimer, préparation et utilisations.

Country Status (6)

Country Link
EP (1) EP0734447A1 (fr)
JP (1) JPH09509059A (fr)
AU (1) AU1815695A (fr)
CA (1) CA2182724A1 (fr)
FR (1) FR2716460B1 (fr)
WO (1) WO1995022616A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706463D0 (en) * 1997-03-27 1997-05-14 Medical Res Council A model of inflamation in the central nervous system for use in the study of disease
CA2392299A1 (fr) * 1999-12-10 2001-06-14 Victor Rivera Procedes d'expression haut niveau de genes chez des primates
US20040093623A1 (en) * 2000-12-20 2004-05-13 Zeger Debyser Non-human animal disease models
KR101890978B1 (ko) 2014-06-17 2018-08-24 서울대학교산학협력단 알츠하이머 질환 모델용 형질전환 돼지 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927908D0 (en) * 1989-12-09 1990-02-14 Medical Res Council Improvements in or relating to alzheimer's disease
EP0451700A1 (fr) * 1990-04-10 1991-10-16 Miles Inc. Minigènes APP recombinants pour l'expression dans des souris transgéniques comme modèles de la maladie d'Alzheimer
WO1993014200A1 (fr) * 1992-01-07 1993-07-22 Tsi Corporation Modeles d'animaux transgeniques utilises pour tester des traitements potentiels relatifs a la maladie d'alzheimer
ATE404683T1 (de) * 1992-09-25 2008-08-15 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
GB9220777D0 (en) * 1992-10-02 1992-11-18 Univ Leicester Oligonucleotide probes

Also Published As

Publication number Publication date
WO1995022616A1 (fr) 1995-08-24
FR2716460A1 (fr) 1995-08-25
EP0734447A1 (fr) 1996-10-02
CA2182724A1 (fr) 1995-08-24
AU1815695A (en) 1995-09-04
JPH09509059A (ja) 1997-09-16

Similar Documents

Publication Publication Date Title
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
PH31406A (en) 6-Substituted mycophenolic acid and derivatives.
NO953262D0 (no) Bedring av Dupuytrens sykdom
NO981388D0 (no) Bedring av Dupuytrens sykdom
MX9102701A (es) Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
DE69604228T2 (de) Pupillen Messanordnung und Alzheimer Krankheits Diagnosesystem
AU1280799A (en) Non-transgenic animal model of alzheimer's disease
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
TR199600612A2 (tr) Ikame edilmis sinamikasitguanidid'leri bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve ayrica bunlari ihtiva eden ilaclar.
ZA962715B (en) Pharmaceutical agents for the treatment of Alzheimer's disease.
FR2716460B1 (fr) Modèle animal de la maladie d'Alzheimer, préparation et utilisations.
FR2719206B1 (fr) Lit d'enfant.
DE69524388D1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
DE69636837D1 (de) 1,2,4-benzotriazinoxid-formulierungen
FR2756564B1 (fr) Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2693194B1 (fr) Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique.
ATE205210T1 (de) 2-azabicyclo(2.2.1)heptan-derivate, ihre herstellung und ihre anwendung
FR2614315B2 (fr) Application de la proteine antigenique p28 a titre d'agent presentant une activite glutathion-s-transferase.
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
FR2715654B1 (fr) Dérivé de N-[3-(1,2,3,4-tétrahydroisoquinoléin-2-yl)-propyl]-N-phényl-5,6,7,8-tétrahydronaphtalène-2-carboxamide, leur préparation et leur application en thérapeutique.
ES1028744Y (es) Juego infantil de fichas.
UA1034S (uk) Міні-пальто хутрове жіноче
UA1033S (uk) Міні-пальто хутрове жіноче
UA1032S (uk) Міні-пальто хутрове жіноче

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20051031